WL-AAJ-Z-W-870- zinc oxide lotion 
Nanophase Technologies Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

WL-AAJ-Z-W-870

WL-AAJ-Z-W-870

GHS Label

WL-AAJ-Z-W-870 
zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63931-4420
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE12 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONOL/PROPYLSILSESQUIOXANE/SILICATE CROSSPOLYMER (450000000 MW) (UNII: 9KB5R958PB)  
ISOPROPYL ISOSTEARATE (UNII: C67IXB9Y7T)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
SQUALANE (UNII: GW89575KF9)  
PROPANEDIOL (UNII: 5965N8W85T)  
WATER (UNII: 059QF0KO0R)  
POLYGLYCERYL-3 RICINOLEATE (UNII: MZQ63P0N0W)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
TRIDECYL SALICYLATE (UNII: AZQ08K38Z1)  
ALLANTOIN (UNII: 344S277G0Z)  
BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)  
NEOPENTYL GLYCOL DIHEPTANOATE (UNII: 5LKW3C543X)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
POLYESTER-7 (UNII: 0841698D2F)  
GLYCERYL BEHENATE/EICOSADIOATE (UNII: 73CJJ317SR)  
ISODECYL SALICYLATE (UNII: S7097PFP4C)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
GLYCERYL STEARATE/PEG-100 STEARATE (UNII: RD25J5V947)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TRIBEHENIN (UNII: 8OC9U7TQZ0)  
GLYCERYL DIBEHENATE (UNII: R8WTH25YS2)  
ISOSTEARIC ACID (UNII: X33R8U0062)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63931-4420-1160000000 mL in 1 DRUM; Type 0: Not a Combination Product03/15/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35203/15/2021
Labeler - Nanophase Technologies Corporation (623502044)
Registrant - Nanophase Technologies Cirporation (623502044)

Revised: 3/2021
Document Id: bd982f11-9fff-56b7-e053-2995a90a6997
Set id: bd982d33-8428-00f6-e053-2995a90a255c
Version: 1
Effective Time: 20210315
 
Nanophase Technologies Corporation